John Chapman

Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.

JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA.

Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium.

RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.

Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Gimv Life Sciences (Gimv-LS) is the venture capital division of Belgium's Gimv NV (XB: GIMB), an investment firm founded in 1980. Based in Antwerp, Gimv-LS manages a variety of funds which focus on investing in European companies in the life sciences / biotech sector, including the Biotech Fonds Vlaanderen, which was established at the request of the Flemish Region to provide venture capital to existing and start-up medium and large-sized companies in the Flemish biotechnology sector.

Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France.

Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA.

Aphelion Capital LLC (Aphelion Capital) is a venture capital firm founded in 2005 by Ned Scheetz and Rodney Altman. The firm is headquartered in Mill Valley, California.

Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany.

Greencoat Capital LLP (Greencoat Capital) is a private equity firm founded by Richard Charles Henry Nourse in 2009. The firm is headquartered in London and having branches in Europe and United States.

SELC Ireland Ltd. manufactures electronic controllers for street lighting. Its products include photocells, ballasts, gear tray, LED drivers, time switches, and NEMA sockets. The firm's solutions optimize the switching on and off and dimming of street lights, and can adjust intensity of lighting based on prevailing conditions. The company was founded by Sean Noone in 1982 and is headquartered in Connacht, Ireland.

Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas.

SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany.

NetXtra Ltd. engages in the provision of digital services. It offers strategy, integration, ecommerce, digital marketing, and support. The company was founded by Robert William Schrimpff and Simon Hardingham in 1995 and is headquartered in Bury St. Edmunds, the United Kingdom.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Siris Medical, Inc. engages in providing treatment for cancer. The company was founded by Nicholas Mourlas and is headquartered in Redwood city, CA.

AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland.

Array Behavioral Care engages in telepsychiatry services. It offers telepsychiatry services for Primary and health care centers, Universities and Schools. The company was founded by James R. Varrell in 2008 and is headquartered in Marlton, NJ.

TVM V LSV Beteiligungsgesellschaft mbH provides investment services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2001.

TVM IV Beteiligungsgesellschaft mbH provides professional, scientific, and technical services. The private company is based in Munich, Germany. The CEOs are Stefan Fischer, Josef Moosholzer. The German company was founded in 2000.

ConcertoCare is a leading risk-based healthcare company that provides at-home, comprehensive care for seniors and adults with unmet health and social needs. The company is based in New York, NY, and has subsidiaries in the United States. The company deploys physician-led interdisciplinary teams, supported by its proprietary population health platform, patient3d®, and clinical decision support tools, to manage the most medically and socially complex and costly patients in ways that keep them in their homes and out of the hospital. ConcertoCare works with a wide variety of payers and can partner with a patient's current primary care physician or serve as the provider of record. Julian Harris has been the CEO of the company since 2021.

Mangrove Management Partners is a healthcare practice management and technology platform company that specializes in the treatment of vascular disease. The company is based in Lexington, MA. The company forms long-term affiliations with vascular providers to optimize the delivery of care and deliver better clinical outcomes at a lower cost. The company was founded in 2020 by Mark H. Rowe, Daniel Gorin, Stephen Hoenig, Paul Mortensen. Mark H. Rowe has been the CEO since 2020.

Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer.